The global transplant diagnostics market size is expected to reach USD 9.74 billion by 2030, registering a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, the adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.
Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to the growing demand for high-throughput diagnostic tools with enhanced accuracy.
Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, the high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.
Gather more insights about the market drivers, restrains and growth of the Transplant Diagnostics Market
Transplant Diagnostics Market Report Highlights
- The sequencing-based typing segment is anticipated to witness significant growth from 2024 to 2030. High adoption of NGS is a major factor driving segment growth
- North America captured the largest revenue share in 2023 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
- Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, the medical tourism industry, and awareness regarding organ donation
Browse more reports published by Grand View Research.
- Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report By Application (Newborn Screening, Infectious Disease Testing, Forensics), By Card Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
- Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report By Brand (QFT-Plus), By Test Type, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
List Of Key Players Transplant Diagnostics Market
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- F. Hoffmann La-Roche Ltd
- Abbott
- QIAGEN
- Bruker
- BD (Becton, Dickinson and Company)
- Werfen (Immucor, Inc.)
- Bio-Rad Laboratories, Inc.
- Omixon Inc.
About Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Explore Horizon, the world's most expansive market research database
